Cronos Group Inc. (CRON) Financials

CRON Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 1.2 billion 48.5 million
Dec. 31, 2025 1.2 billion 54.2 million
Sept. 30, 2025 1.2 billion 46.4 million
June 30, 2025 1.2 billion 45.0 million

CRON Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 8.9 million 1.3 million
Dec. 31, 2025 9.9 million -5.8 million
Sept. 30, 2025 8.7 million 2.3 million
June 30, 2025 -1.0 million 1.4 million

CRON Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 13.6 million
Dec. 31, 2025 2.4 million
Sept. 30, 2025 28.3 million
June 30, 2025 -38.5 million

CRON Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 824.6 million - 1.1 million
Dec. 31, 2025 831.8 million - 1.5 million
Sept. 30, 2025 824.2 million - 1.7 million
June 30, 2025 834.4 million - 2.0 million

CRON Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 385.3 million
Dec. 31, 2025 385.3 million
Sept. 30, 2025 385.3 million
June 30, 2025 385.3 million

CRON Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.8 million 1.4 million 17.4 million 5.6 million
Dec. 31, 2025 2.2 million 1.4 million 13.6 million 6.6 million
Sept. 30, 2025 4.6 million 1.3 million 16.9 million 5.3 million
June 30, 2025 3.8 million 929000 17.3 million 5.3 million

CRON Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 44.6 million 26.1 million
Dec. 31, 2025 91.3 million 75.1 million
Sept. 30, 2025 36.3 million 18.0 million
June 30, 2025 33.5 million 19.0 million

CRON Revenue by Segment

Graph available only for paid members. Upgrade to see it.

CRON

Price: $2.82

52 week price:
1.93
3.43

Payout Ratio Range:
-0.75%
-0.49%

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Canada

Volume: 1.5 million

Market Capitalization: 1.1 billion

Links: